Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors

NCT07107230 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.

NCT NCT07107230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07107230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors
Lead sponsor
Janssen Research & Development, LLC
Phase
Phase 1
Overall status
Recruiting
Start date
July 15, 2025
Completion date
April 24, 2028
Enrollment
400 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

advanced stage solid tumors